Novel Tear Biomarkers in Ocular Graft Versus Host Disease Associated with Th1/Th2 Immune Responses: A Case Series and Literature Review
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094311 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mihaela-Madalina Timofte-Zorila und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Biomarkers, Dry Eye Syndromes, Graft vs Host Disease, Tears. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian Ministry of Research, Innovation and Digitization, CNCS - UEFISCDI, Grigore T. Popa University of Medicine and Pharmacy of Iasi, Romanian Ministry of Research, Innovation and Digitization, CNCS-UEFISCDI.
Abstract (Originalsprache)
Ocular graft versus host disease (oGVHD) is a common complication of allogeneic hematopoietic stem cell transplantation and may be associated with dry eye disease and chronic inflammation and fibrosis. Immune dysregulation, particularly the Th1/Th2 imbalance, plays a key role in the progression of oGVHD. This case study presents two oGVHD patients (a 20-year-old with acute oGVHD and a 59-year-old with chronic oGVHD), analyzing clinical dry eye parameters (Schirmer test I, tear film break-up time, Ocular Surface Disease Index (OSDI), and kerato-conjunctival staining) alongside tear biomarkers. A 27-plex tear cytokine analysis was performed using the Luminex200 platform, assessing various biomarkers against a control group-defined normal range. Key biomarkers included beta2-microglobulin (β2-MG), complement components, chemokines, growth factors, and both pro-inflammatory and anti-inflammatory cytokines, as well a series of soluble ligand and receptors. The study identified distinct biomarker progression patterns during topical corticosteroid treatment in the acute oGHVD patient, suggesting potential shifts in Th1/Th2 responses as the disease progressed. Notably, the soluble CD27, TNF-related apoptosis-inducing ligand (TRAIL) receptor 2 (TRAIL-R2), chemokine ligand 2 (CCL2), and IL-1β, initially elevated, normalized during treatment, while tear-soluble Fas remained highly elevated (>400-fold). Conversely, soluble TRAIL, which was initially at very low levels (100-fold lower), increased during treatment and reached normal tear levels, coinciding with improvements in the clinical ocular inflammation symptoms and OSDI score. This case study also highlights potential differences between acute and chronic oGVHD, particularly in the distinct patterns of novel tear biomarkers such as CD27, TRAIL/TRAIL-R2, and CCL2. Enhancing our understanding of biomarker dynamics may improve disease monitoring and pave the way for personalized management strategies to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Department of Ophthalmology, Cai Ferate Clinical Hospital, 700506 Iasi, Romania.
- Department of Immunology, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Laboratory of Immunology, St. Spiridon County Clinical Emergency Hospital, 700111 Iasi, Romania.
- Eye Clinic, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.
- Department of Hematology, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
ORCID-Profile: Mariana Pavel-Tanasa, Daniela Constantinescu, Daniel Constantin Branisteanu, Giuseppe Giannaccare, Filippo Lixi
Förderung
- Romanian Ministry of Research, Innovation and Digitization, CNCS - UEFISCDI
- Grigore T. Popa University of Medicine and Pharmacy of Iasi
- Romanian Ministry of Research, Innovation and Digitization, CNCS-UEFISCDI
Zitieren
APA
Timofte-Zorila, M. M., Pavel-Tanasa, M., Constantinescu, D., Cianga, C., Branisteanu, D. C., Giannaccare, G., Lixi, F., Dascalescu, A., Vlas, N., Turcas, S., & Preda, C. (2025). Novel Tear Biomarkers in Ocular Graft Versus Host Disease Associated with Th1/Th2 Immune Responses: A Case Series and Literature Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094311
Vancouver
Timofte-Zorila MM, Pavel-Tanasa M, Constantinescu D, Cianga C, Branisteanu DC, Giannaccare G, et al. Novel Tear Biomarkers in Ocular Graft Versus Host Disease Associated with Th1/Th2 Immune Responses: A Case Series and Literature Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094311
BibTeX
@article{TimofteZorila2025,
author = {Timofte-Zorila, Mihaela-Madalina and Pavel-Tanasa, Mariana and Constantinescu, Daniela and Cianga, Corina and Branisteanu, Daniel Constantin and Giannaccare, Giuseppe and Lixi, Filippo and Dascalescu, Angela and Vlas, Nicoleta and Turcas, Sabina and Preda, Cristina},
title = {Novel Tear Biomarkers in Ocular Graft Versus Host Disease Associated with Th1/Th2 Immune Responses: A Case Series and Literature Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094311}
}
EUVIMED